MetaCap

Context Therapeutics (CNTX) News

NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.16-0.0086 (-5.10%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CNTX news summary

We found 3 recent headlines mentioning Context Therapeutics (CNTX): 0 in the past week and 1 in the past 30 days, most often from Nasdaq, GlobeNewswire. CNTX is making an outsized move today, down 5.10% at $0.16, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Context Therapeutics Reports Third Quarter 2026 Financial Results and Pipeline Progress", was published by GlobeNewswire on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Context Therapeutics headlines

Stocks mentioned alongside CNTX

Compare CNTX